Levaquin, Levofloxacin

Levaquin, Levofloxacin Newswire

Comprehensive Real-Time News Feed for Levaquin, Levofloxacin (generic).

Results 1 - 20 of 48 in Levaquin, Levofloxacin (generic)

  1. Daddy's death in a nursing home due to dangerous drugs part sevenRead the original story w/Photo

    Wednesday Sep 24 | Examiner.com

    Daddy was my sunshine on a cloudy day, while I was the apple of his eye. So, when I got a phone call from my younger brother, telling me that Daddy had died, I almost passed out.

    Comment?

  2. Pulmonary Disease Caused by Mycobacterium marseillense, ItalyRead the original story

    Tuesday Sep 23 | Centers for Disease Control and Prevention

    To the Editor : Mycobacterium marseillense was recently described as a new species belonging to the Mycobacterium avium complex . We describe a case of pulmonary disease caused by M. marseillense in an immunocompetent patient.

    Comment?

  3. Zhejiang Jingxin Pharmaceutical Co., Ltd (002020) - Pharmaceuticals & ...Read the original story

    Saturday Sep 20 | PR-inside.com

    The company manufactures and markets pharmaceutical products. Its product portfolio includes finished dosage forms, Chinese herbal drugs and APIs.

    Comment?

  4. Critics demand stronger warnings for potent antibioticsRead the original story w/Photo

    Wednesday Sep 17 | USA Today

    GLENDALE, Ariz. - A powerful antibiotic prescribed to cure strep throat may have been more debilitating for one woman than her sickness ever was.

    Comment?

  5. Antibiotics Linked to Lows in People Taking Certain Diabetes DrugsRead the original story

    Thursday Sep 11 | Diabetes Self Management

    A new study from researchers at the University of Texas has linked certain antibiotics to hypoglycemia in older people taking sulfonylureas , a class of oral diabetes medicine prescribed to treat Type 2 diabetes. An estimated 26 million people in the United States have Type 2 diabetes.

    Comment?

  6. LawyersandSettlements.com Interviews Lead Author On Study Showing...Read the original story

    Monday Sep 8 | PRWeb

    A year after the US Food and Drug Administration addressed the subject of a label change for fluoroquinolones that pose a risk for Peripheral Neuropathy , a new Canadian study suggests the risk for PN among users of fluoroquinolone-based antibiotics is double that of non-users. LawyersandSettlements.com now interviews the lead author of the study, Dr. Mahyar Etminan, PharmD.

    Comment?

  7. TetraPhase Pharmaceuticals Announces Positive Oral Dosing Data From...Read the original story

    Wednesday Sep 3 | BioSpace

    Tetraphase Pharmaceuticals, Inc. today announced that positive top-line results from the lead-in portion of its IGNITE 2 clinical trial, a two-part Phase 3 clinical trial studying the efficacy and safety of intravenous and oral formulations of eravacycline for the treatment of complicated urinary tract infections , support advancement of the trial ... (more)

    Comment?

  8. Tetraphase Oral Antibiotic Data Look GoodRead the original story w/Photo

    Wednesday Sep 3 | TheStreet.com

    The study enrolled patients with complicated urinary tract infections . Tetraphase only provided a summary of the IV-to-oral dosing data, but the company concluded oral eravacycline efficacy and tolerability were sufficient to move ahead with the second part of the phase III study in the fourth quarter.

    Comment?

  9. Popular antibiotics implicated in nerve damage, says study with B.C. linksRead the original story w/Photo

    Tuesday Sep 2 | Edmonton Journal

    A popular class of oral antibiotics doubles the risk of experiencing permanent nerve damage , according to new research published in the journal Neurology .

    Comment?

  10. Tetraphase says urinary drug successful in late-stage studyRead the original story

    Tuesday Sep 2 | Reuters

    Drugmaker Tetraphase Pharmaceutical Inc said its experimental drug to treat complicated urinary tract infections compared favorably to standard treatment in the first portion of a two-part late-stage trial.

    Comment?

  11. Tetraphase Pharmaceuticals Announces Positive Oral Dosing Data from...Read the original story

    Tuesday Sep 2 | Business Wire

    Tetraphase Pharmaceuticals, Inc. today announced that positive top-line results from the lead-in portion of its IGNITE 2 clinical trial, a two-part Phase 3 clinical trial studying the efficacy and safety of intravenous and oral formulations of eravacycline for the treatment of complicated urinary tract infections , support advancement of the trial ... (more)

    Comment?

  12. Daiichi Sankyo Espha Receives Manufacturing and Marketing License in...Read the original story

    Monday Sep 1 | PressReleasePoint

    Daiichi Sankyo Company, Limited today announced that its domestic generic drug subsidiary, Daiichi Sankyo Espha Co., Ltd. , obtained a manufacturing and marketing license in Japan on August 15, 2014 for Levofloxacin Tablets 250mg DSEP, 500mg DSEP and Granules 10% DSEP .

    Comment?

  13. Baron & Budd Files First Litigation in Levaquin, Avelox, and Cipro CasesRead the original story w/Photo

    Aug 26, 2014 | Business Wire

    The Dallas-based national law firm of Baron & Budd, P.C., a leader in pharmaceutical litigation, has filed the first lawsuit involving a form of nerve damage known as peripheral neuropathy against pharmaceutical companies which marketed a class of powerful antibiotics called "fluoroquinolones" .

    Comment?

  14. Popular antibiotics implicated in nerve damage, says study with B.C. linksRead the original story w/Photo

    Aug 23, 2014 | Edmonton Journal

    A popular class of oral antibiotics doubles the risk of experiencing permanent nerve damage, according to new research published in the journal Neurology.

    Comment?

  15. Notes from the Field: Atypical Pneumonia in Three Members of an...Read the original story

    Aug 21, 2014 | Centers for Disease Control and Prevention

    Notes from the Field: Atypical Pneumonia in Three Members of an Extended Family - South Carolina and North Carolina, JulyaS'August 2013 On August 5, 2013, the South Carolina Department of Health and Environmental Control was notified of a case of acute respiratory failure in a previously healthy woman.

    Comment?

  16. Invasive Infection Caused by Carbapenem-Resistant Acinetobacter soli, JapanRead the original story

    Aug 19, 2014 | Centers for Disease Control and Prevention

    To the Editor: Infections caused by Acinetobacter spp., especially A. baumannii , have been increasingly documented in recent years.

    Comment?

  17. Use of drug susceptibility testing to select therapy improves...Read the original story

    Aug 13, 2014 | Aidsmap

    New research published in the online edition of Clinical Infectious Diseases supports World Health Organization recommendations for the use of drug susceptibility testing to select drugs for the treatment of drug-resistant tuberculosis.

    Comment?

  18. Use of drug susceptibility testing to select therapy improves...Read the original story

    Aug 13, 2014 | Aidsmap

    New research published in the online edition of Clinical Infectious Diseases supports World Health Organization recommendations for the use of drug susceptibility testing to select drugs for the treatment of drug-resistant tuberculosis.

    Comment?

  19. Levofloxacin-Resistant Haemophilus influenzae, Taiwan, 2004 - "2010Read the original story w/Photo

    Jul 19, 2014 | Centers for Disease Control and Prevention

    National Health Research Institutes, Zhunan, Taiwan Levofloxacin resistance in Haemophilus influenzae has increased significantly in Taiwan, from 2.0% in 2004 to 24.3% in 2010 .

    Comment?

  20. FDA's Pathway For Hospital Acquired Pneumonia - It's Feasible But StupidRead the original story

    Jul 3, 2014 | Scientific Blogging

    Ph.D in Microbiology and M.D. from Case Western Reserve. BA, Biology-Chemistry from Lawrence University.

    Comment?